Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agent Failure
A 24-week, Multicenter, International, Randomized (1:1), Parallel-group, Open-label, Comparative Study of Insulin Glargine Versus Liraglutide in Insulin-naïve Patients With Type 2 Diabetes Treated With Oral Agents and Not Adequately Controlled, Followed by a 24-week Extension Period With Insulin Glargine for Patients Not Adequately Controlled With Liraglutide
Status: Archived
Clinical Research Facility
mi
from
Dallas, TX
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agent Failure
A 24-week, Multicenter, International, Randomized (1:1), Parallel-group, Open-label, Comparative Study of Insulin Glargine Versus Liraglutide in Insulin-naïve Patients With Type 2 Diabetes Treated With Oral Agents and Not Adequately Controlled, Followed by a 24-week Extension Period With Insulin Glargine for Patients Not Adequately Controlled With Liraglutide
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Dallas, TX
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agent Failure
A 24-week, Multicenter, International, Randomized (1:1), Parallel-group, Open-label, Comparative Study of Insulin Glargine Versus Liraglutide in Insulin-naïve Patients With Type 2 Diabetes Treated With Oral Agents and Not Adequately Controlled, Followed by a 24-week Extension Period With Insulin Glargine for Patients Not Adequately Controlled With Liraglutide
Status: Archived
Clinical Research Facility
mi
from
Dallas, TX
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agent Failure
A 24-week, Multicenter, International, Randomized (1:1), Parallel-group, Open-label, Comparative Study of Insulin Glargine Versus Liraglutide in Insulin-naïve Patients With Type 2 Diabetes Treated With Oral Agents and Not Adequately Controlled, Followed by a 24-week Extension Period With Insulin Glargine for Patients Not Adequately Controlled With Liraglutide
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Dallas, TX
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agent Failure
A 24-week, Multicenter, International, Randomized (1:1), Parallel-group, Open-label, Comparative Study of Insulin Glargine Versus Liraglutide in Insulin-naïve Patients With Type 2 Diabetes Treated With Oral Agents and Not Adequately Controlled, Followed by a 24-week Extension Period With Insulin Glargine for Patients Not Adequately Controlled With Liraglutide
Status: Archived
Clinical Research Facility
mi
from
Renton, WA
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agent Failure
A 24-week, Multicenter, International, Randomized (1:1), Parallel-group, Open-label, Comparative Study of Insulin Glargine Versus Liraglutide in Insulin-naïve Patients With Type 2 Diabetes Treated With Oral Agents and Not Adequately Controlled, Followed by a 24-week Extension Period With Insulin Glargine for Patients Not Adequately Controlled With Liraglutide
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Renton, WA
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agent Failure
A 24-week, Multicenter, International, Randomized (1:1), Parallel-group, Open-label, Comparative Study of Insulin Glargine Versus Liraglutide in Insulin-naïve Patients With Type 2 Diabetes Treated With Oral Agents and Not Adequately Controlled, Followed by a 24-week Extension Period With Insulin Glargine for Patients Not Adequately Controlled With Liraglutide
Status: Archived
Clinical Research Facility
mi
from
Spokane, WA
Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agent Failure
A 24-week, Multicenter, International, Randomized (1:1), Parallel-group, Open-label, Comparative Study of Insulin Glargine Versus Liraglutide in Insulin-naïve Patients With Type 2 Diabetes Treated With Oral Agents and Not Adequately Controlled, Followed by a 24-week Extension Period With Insulin Glargine for Patients Not Adequately Controlled With Liraglutide
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Spokane, WA
Management of Diabetes With Metformin In Patients With Chronic Heart Failure
Management of Diabetes With Metformin In Patients With Chronic Heart Failure
Status: Archived
Ahmanson-UCLA Cardiomyopathy Center
mi
from
Los Angeles, CA
Management of Diabetes With Metformin In Patients With Chronic Heart Failure
Management of Diabetes With Metformin In Patients With Chronic Heart Failure
Status: Archived
Updated: 1/1/1970
Ahmanson-UCLA Cardiomyopathy Center
mi
from
Los Angeles, CA
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Veterans Affairs Medical Center, Washington D.C.
mi
from
Washington D.C.,
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center, Washington D.C.
mi
from
Washington D.C.,
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Scottsdale, AZ
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Scottsdale, AZ
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Miami, FL
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Miami, FL
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
mi
from
Scarborough, ME
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
mi
from
Scarborough, ME
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Topeka, KA
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Topeka, KA
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Hazard, KY
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Hazard, KY
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Lansing, MI
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Lansing, MI
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Nashua, NH
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Nashua, NH
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Brooklyn, NY
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Brooklyn, NY
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Chapel Hill, NC
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chapel Hill, NC
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Portland, OR
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Portland, OR
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
New York Methodist Hospital
mi
from
Brooklyn, NY
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
New York Methodist Hospital
mi
from
Brooklyn, NY
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Fort Worth, TX
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Worth, TX
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Norfolk, VA
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Norfolk, VA
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Seattle, WA
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Seattle, WA
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Clinical Research Facility
mi
from
Burlington, WI
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-3)
The Impact of LY2189265 Versus Metformin on Glycemic Control in Early Type 2 Diabetes Mellitus (AWARD-3: Assessment of Weekly AdministRation of LY2189265 in Diabetes-3)
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Burlington, WI
Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens
Phase IV Study of the Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-Economic Comparison of Daptomycin vs Vancomycin Based Regimens
Status: Archived
Infuscience
mi
from
Annandale, VA
Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens
Phase IV Study of the Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-Economic Comparison of Daptomycin vs Vancomycin Based Regimens
Status: Archived
Updated: 1/1/1970
Infuscience
mi
from
Annandale, VA
Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens
Phase IV Study of the Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-Economic Comparison of Daptomycin vs Vancomycin Based Regimens
Status: Archived
Clinical Alliance for Research and Education - Infectious Diseases, LLC
mi
from
Annandale, VA
Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens
Phase IV Study of the Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-Economic Comparison of Daptomycin vs Vancomycin Based Regimens
Status: Archived
Updated: 1/1/1970
Clinical Alliance for Research and Education - Infectious Diseases, LLC
mi
from
Annandale, VA
Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes
Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes
Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Veterans Affairs Medical Center, Washington D.C.
mi
from
Washington D.C.,
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center, Washington D.C.
mi
from
Washington D.C.,
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Clinical Research Facility
mi
from
Miami, FL
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Miami, FL
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Updated: 1/1/1970
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Clinical Research Facility
mi
from
Topeka, KA
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Topeka, KA
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Clinical Research Facility
mi
from
Scarborough, ME
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Scarborough, ME
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Hartford Hospital- The Institute of Living
mi
from
Hartford, CT
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Updated: 1/1/1970
Hartford Hospital- The Institute of Living
mi
from
Hartford, CT
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Clinical Research Facility
mi
from
Cincinnati, OH
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Cincinnati, OH
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Cotton-O'Neil Cancer Center
mi
from
Topeka, KA
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Updated: 1/1/1970
Cotton-O'Neil Cancer Center
mi
from
Topeka, KA
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Clinical Research Facility
mi
from
Chattanooga, TN
Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin
Randomized Clinical Trial of Subcutaneous Analog Basal Bolus Therapy Versus Sliding Scale Human Regular Insulin in the Hospital Management of Hyperglycemia in Non-Critically Ill Patients Without Known History of Diabetes: The HMH Trial
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chattanooga, TN
Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
Symlin® Dose Escalation Efficacy vs. Conventional Therapy in Type 2 Diabetes Mellitus
Status: Archived
North Jersey Endocrine Consultants
mi
from
Denville, NJ
Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
Symlin® Dose Escalation Efficacy vs. Conventional Therapy in Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
North Jersey Endocrine Consultants
mi
from
Denville, NJ
Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
Symlin® Dose Escalation Efficacy vs. Conventional Therapy in Type 2 Diabetes Mellitus
Status: Archived
University Physicians Group
mi
from
Staten Island, NY
Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
Symlin® Dose Escalation Efficacy vs. Conventional Therapy in Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
University Physicians Group
mi
from
Staten Island, NY
Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
Symlin® Dose Escalation Efficacy vs. Conventional Therapy in Type 2 Diabetes Mellitus
Status: Archived
St. Mary - Corwin Medical Center
mi
from
Pueblo, CO
Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus
Symlin® Dose Escalation Efficacy vs. Conventional Therapy in Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
St. Mary - Corwin Medical Center
mi
from
Pueblo, CO
A Lifestyle Intervention to Prevent Gestational Diabetes
Estudio VIDA (Valoración e Intervención Dietética y de Actividad Física): A Pilot Lifestyle Intervention for Gestational Diabetes Among Hispanic Women
Status: Archived
Baystate Med Ctr of Springfield
mi
from
Springfield, MA
A Lifestyle Intervention to Prevent Gestational Diabetes
Estudio VIDA (Valoración e Intervención Dietética y de Actividad Física): A Pilot Lifestyle Intervention for Gestational Diabetes Among Hispanic Women
Status: Archived
Updated: 1/1/1970
Baystate Med Ctr of Springfield
mi
from
Springfield, MA
A Lifestyle Intervention to Prevent Gestational Diabetes
Estudio VIDA (Valoración e Intervención Dietética y de Actividad Física): A Pilot Lifestyle Intervention for Gestational Diabetes Among Hispanic Women
Status: Archived
Mercy Medical Center
mi
from
Springfield, MA
A Lifestyle Intervention to Prevent Gestational Diabetes
Estudio VIDA (Valoración e Intervención Dietética y de Actividad Física): A Pilot Lifestyle Intervention for Gestational Diabetes Among Hispanic Women
Status: Archived
Updated: 1/1/1970
Mercy Medical Center
mi
from
Springfield, MA
Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers
Comparison of SANTYL vs. Hydrogel in Debridement of Inflamed Diabetic Foot Ulcers
Status: Archived
Richard C. Galperin, DPM
mi
from
Dallas, TX
Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers
Comparison of SANTYL vs. Hydrogel in Debridement of Inflamed Diabetic Foot Ulcers
Status: Archived
Updated: 1/1/1970
Richard C. Galperin, DPM
mi
from
Dallas, TX
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Veterans Affairs Medical Center, Washington D.C.
mi
from
Washington D.C.,
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center, Washington D.C.
mi
from
Washington D.C.,
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Clinical Research Facility
mi
from
Scottsdale, AZ
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Scottsdale, AZ
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Clinical Research Facility
mi
from
Miami, FL
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Miami, FL
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Aurora Memorial Hospital of Burlington
mi
from
Burlington, WI
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
University of Vermont College of Medicine
mi
from
Burlington, VT
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients With Type 2 Diabetes Mellitus
Status: Archived
Updated: 1/1/1970
University of Vermont College of Medicine
mi
from
Burlington, VT